Introduction Recommendations give advice to doctors and patients about the best way to treat and manage diseases. EULAR has written recommendations on the management of people with systemic lupus erythematosus (also called SLE or Lupus for short). Lupus is an autoimmune disease where the immune system attacks the body’s own tissues and causes inflammation. Lupus […]
Month: March 2017
MRI may be a valid biomarker in RA
MRI measures of inflammation and structural damage correlate independently with physical function, pain and patient global assessments INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It is more common in older people, and affects both men and women. The use of patient-reported outcomes (often shortened to […]
Secukinumab is effective in biologic-naïve and -experienced patients
Secukinumab provides sustained improvements in signs and symptoms of ankylosing spondylitis INTRODUCTION Spondyloarthritis is an umbrella term for several conditions that share many of the same features and symptoms, including ankylosing spondylitis, psoriatic arthritis and reactive arthritis. Patients can also be classified as having axial or non-axial (peripheral) disease, according to which joints in their […]
Towards a universally accepted definition of remission in lupus
A framework for testing different definitions of remission against long-term outcomes INTRODUCTION Systemic lupus erythematosus (also known as SLE or lupus) is an autoimmune disease. It typically affects women between the ages of 15 and 50, and symptoms flare up unpredictably. Lupus is caused by complicated interactions between the immune system and environmental factors leading […]